These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17537361)

  • 1. [Adequacy of the treatment of hypertensive patients with metabolic syndrome].
    Barrios V; Escobar C; Calderón A; Llisterri JL; Alegría E; Muñiz J; Matalí A
    Med Clin (Barc); 2007 May; 128(17):647-51. PubMed ID: 17537361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus in hypertensive population attended in Primary Care in Spain. Blood pressure and lipid control rates].
    Escobar C; Barrios V; Calderón A; Llisterri JL; García S; Rodríguez-Roca GC; Matalí A
    Rev Clin Esp; 2007 May; 207(5):221-7. PubMed ID: 17504665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study].
    Barrios V; Escobar C; Llisterri JL; Calderón A; Alegría E; Muñiz J; Matalí A
    Rev Clin Esp; 2007 Apr; 207(4):172-8. PubMed ID: 17475179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of metabolic syndrome in the control of blood pressure and dyslipemia].
    Rodilla E; García L; Merino C; Costa JA; González C; Pascual JM
    Med Clin (Barc); 2004 Nov; 123(16):601-5. PubMed ID: 15546516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Syndrome-Related Features in Controlled and Resistant Hypertensive Subjects.
    Catharina AS; Modolo R; Ritter AMV; Sabbatini AR; Lopes HF; Moreno Junior H; Faria AP
    Arq Bras Cardiol; 2018 Jun; 110(6):514-521. PubMed ID: 30226908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population].
    de la Sierra A; Romero R; Bonet J; Pérez M; López JS; Ravella R; Aguilera MT;
    Med Clin (Barc); 2006 Mar; 126(11):406-9. PubMed ID: 16595083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
    Wang F; Ye P; Hu D; Min Y; Zhao S; Wang Y; Mu Y; Yan X; Li Z; Wei Y; Li J;
    Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of the presence of cardiovascular disease on blood pressure and lipid control in the hypertense population attended in primary care].
    Barrios Alonso V; Escobar Cervantes C; Calderón Montero A; Llisterri Caro JL; Echarri Carrillo R; Matalí A
    Aten Primaria; 2008 Jan; 40(1):21-7. PubMed ID: 18190764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls.
    Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH
    Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome among hypertensive patients at University of Gondar Hospital, North West Ethiopia: a cross sectional study.
    Tachebele B; Abebe M; Addis Z; Mesfin N
    BMC Cardiovasc Disord; 2014 Dec; 14():177. PubMed ID: 25481843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum long-acting natriuretic peptide level correlates with metabolic syndrome in hypertensive patients: a cross-sectional study.
    Hsieh JC; Wang JH; Lee CJ; Chen YC; Liou HH; Hsu BG
    Arch Med Res; 2013 Apr; 44(3):215-20. PubMed ID: 23506722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma concentrations in newly diagnosed hypertension patients and the metabolic effects of olmesartan.
    Akyürek Ö; Akbal E; Güneş F; Akyürek N
    Arch Med Res; 2014 Feb; 45(2):138-42. PubMed ID: 24480732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
    Tadewos A; Egeno T; Amsalu A
    BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome.
    Shin MJ; Shim E; Kang B; Park S; Lee SH; Shim CY; Park E; Chung N
    Yonsei Med J; 2009 Dec; 50(6):757-63. PubMed ID: 20046414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
    Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
    Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
    Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
    Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients.
    Osuji CU; Omejua EG
    Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S104-9. PubMed ID: 22701827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cardiovascular risk factors in hypertensive subjects with metabolic syndrome defined by three different definitions.
    Shrestha R; Jha SC; Khanal M; Gyawali P; Yadav BK; Jha B
    JNMA J Nepal Med Assoc; 2011; 51(184):157-63. PubMed ID: 22922894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.